Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: Importance of intervention timings

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 1, 2000, Pages 88-95

  Jacobs, S ^a   Sobki, S ^a   Morais, C ^a   Tariq, M ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Fecal peritonitis; Free radicals; Pentaglobin; Piperacillin; Sepsis

Indexed keywords

IMMUNOGLOBULIN G; PIPERACILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL TIME;

ANIMALS; FECES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PENICILLINS; PERITONITIS; PIPERACILLIN; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIME FACTORS;

EID: 0033979337     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.440116.x     Document Type: Article

References (45)

1. 1 Perdue PW, Kazarian KK, Nevola J, Low WR, Williams T. The use of local and systemic antibiotics in rat faecal peritonitis. J Surg Res 1994: 57: 360-365.
2. 2. Schein M. Planned reoperations and open management in critical intra abdominal infections: Prospective experience in 52 cases. World J Surg 1991: 15: 537-545.
3. 3. Tracey KJ, Vlassara H, Cerami A. Cathectin/tumour necrosis factor. Lancet 1989: 1: 1122-1126.
4. 4. Wolf SM. Biological effects of bacterial endotoxin in men. J Infect Dis 1973: 123 (Suppl 1): 259-264.
5. 5. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BJ, Palladiono MA Jr. Activation of human polymorphonuclear neutrophil functions by interferon gamma and tumour necrosis factors. J Immunol 1985: 135: 2069-2073.
6. 6. Harris RL, Musher RM, Bloom K. Manifestations of sepsis. Arch Intern Med 1987: 147: 1895-1906.
7. 7. Gallin JI. Degranulating stimuli decrease the negative surface charge and increase the adhesiveness of human neutrophils. J Clin Invest 1980: 65: 298-306.
8. 8. Khinev S, Dafinova K, Koinova G, Dimitrov P, Ivanov A, Bakalova R. The induction of lipid peroxidation in the serum of patients with acute peritonitis. Khirurgiia 1996: 49: 27-29.
9. 9. Koniukhova SG, Dubikaitis AI, Shabunevich LV, Strashnov VI, Belotserkovskii MV. Effects of plasmapheresis on the activity of lipid peroxidation in peritonitis. Anesteziol Reanimatol 1993: 3: 62-65.
10. 10. Walsh GI, Cheasson P, Hedderich G, Wexler MJ, Meakins JL. The open abdomen. The martex mesh and zipper technique: A method of managing intraperitoneal infection. Surg Clin N Am 1998: 68: 25-40.
11. 11. Cohen J, Mc Connell JS. Antibiotic-induced endotoxin release. Lancet 1985: ii: 1069-1070.
12. 12. Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: Correlation with clinical outcome and determination of anti-endotoxin core anti-bodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrob Agents Chemother 1992: 36: 2139-2146.
13. 13. Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S et al. Treatment of gram-negative septic shock with an immunoglobulin preparation: a perspective, randomized clinical trial. Crit Care Med 1991: 19: 1104-1113.
14. 14. Stephen W, Dichtelmuller H, Schedel I. Properties and efficacy of a human immunoglobulin M preparation for intravenous administration. Drug Res 1985: 35: 933-936.
15. 15. Ziegler EJ, Fisher CJ, Sprung CL. Treatment of gram negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin. N Engl J Med 1991: 324: 429-436.
16. 16. Jaccard C, Troillet N, Harbarth S, Zanetti G, Aymon D, Schneider R et al. Prospective randomized comparison of imipenemcilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis. Antimicrob Agents Chemother 1998: 42: 2966-2972.
17. 17. Elsakr R, Johnson DA, Younes Z, Oldfield EC. Antimicrobial treatment of intra-abdominal infections. Dig Dis 1998: 16: 47-60.
18. 18. Simopoulos C, Kouskoukis C, Polychromides A, Bezirtzoglou E. Effect of different combinations of antibiotics on experimental septic peritonitis in rabbits. Int J Clin Lab Res 1994: 24: 167-170.
19. 19. Arguedas A, Sifuentes-Osornio J, Loaiza C, Herrera M, Corrales JC, Mohs E. An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections. J Chemother 1996: 8: 130-136.
20. 20. Almdahl GM, Nordstrand K, Melby K, Osterud B, Giercksky KE. Faecal peritonitis in the rat. Acta Chir Scand 1985: 151: 213-216.
21. 21. Wichterman KA, Ban AE, Chaudry IH. Sepsis and peptic shock. A review of laboratory models and a proposal. J Surg Res 1980: 29: 189-200.
22. 22. Motew Sf, Sam AD, Mourelatos MG, Sharma AC, Alden KJ, Ferguson JL et al. Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. J Surg Res 1998: 80: 326-332.
23. 23. Jacobi CA, Ordemann J, Zieren HV, Volk HD, Bauhofer A, Halle E et al. Increased systemic inflammation after laparotomy vs laparoscopy in our animal model of peritonitis. Arch Surg 1998: 133: 258-262.
24. 24. Shic CS, Akimasa N, Wakahiko K, Akio H, Toshiaki N, Minoru N et al. The ability of polymorphonuclear leukocytes to produce active oxygen in a model of peritonitis. Jpn J Surg 1993: 23: 603-608.
25. 25. Nakao A, Yasui M, Shen S, Takagi H. Immunohistochemical staining for endotoxin using horseshoe crab factor C in fecal peritonitis. Eur Surg Res 1995: 27: 216-221.
26. 26. Noronha-Blob N, Lowe VC, Otterbein L, Steranka L, Burch RM. NPC 15669 reduces mortality associated with sepsis in rats. J Pharmacol Exp Ther 1993: 267: 664-669.
27. 27. Misra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972: 247: 3170-3175.
28. 28. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984: 105: 114-121.
29. 29. Baudhuin P, Beaufay H, Rahman Li Y, Sellinger OZ, Watliaux R, Jacques P et al. Intracellular distribution of monoamine oxidase aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat liver tissue. Biochem J 1964: 92: 179-184.
30. 30. Dichtelmuller H, Stephen W. Studies on the efficacy of immunoglobulin M enriched intravenous immunoglobulin against bacterial infections and neutralization of bacterial toxins. Drug Res 1987: 37: 1273-1276.
31. 31. Neu HC. Therapy and prophylaxis of bacterial infections. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK, eds. Harrison's principles of internal medicine, 12th edn. New York: McGraw-Hill, 1991: 485.
32. 32. Natansan C, Damner RL, Reilly JM, Doerfler M, Hoffman WD, Akin GL et al. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 1990: 2959: 1440-1447.
33. 33. Greenmann RL, Schein RMH, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991: 226: 1097-1102.
34. 34. Cafiero F, Gipponi M, Bonalumi U. Prophylaxis of infection with intravenous immunoglobulins plus antibiotics for patients at risk for sepsis undergoing surgery for colorectal cancer: results of randomized multicentre clinical trial. Surgery 1992: 112: 24-31.
35. 35. Shenep JL, Barton RP, Morgan KA. Role of antibiotics class in the rate of liberation of endotoxin during therapy for experimental gram negative bacterial sepsis. J Infect Dis 1985: 151: 1012-1018.
36. 35. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR, Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1992: 23: 646-651.
37. 37. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 1996: 24: 1179-1183.
38. 38. Ogilvie AC, Groeneveld ABJ, Straub JP, Thigs LG. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991: 17: 40-44.
39. 39. Goode HF, Webster NR. Free radicals and antioxidants in sepsis. Crit Care Med 1993: 21: 1770-1776.
40. 40. Leff JA, Parsons PE, Day CE, Moore EE, Moore FA, Oppegard MA et al. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992: 146: 985-989.
41. 41. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984: 73: 87-95.
42. 42. Tuncel P, Gur ES, Kaya E, Ozbek R, Ozturk E, Tokyay R. Effects of vitamin E and cimetidine on peritonitis-induced lipid peroxidation. Res Exp Med 1997: 197: 235-241.
43. 43. Demling R, LaLonde C, Ikegami K, Picard L, Nayak U. Alpha-tocopherol attenuates lung edema and lipid peroxidation caused by acute zymosan-induced peritonitis. Surgery 1995: 117: 226-231.
44. 44. Kim YM, Hong SJ, Billiar TR, Simmons RL. Counter protective effect of erythrocytes in experimental bacterial peritonitis is due to scavenging of nitric oxide and reactive oxygen intermediates. Infect Immun 1996: 64: 3074-3080.
45. 45. Sies H. Oxidative stress: oxidants and antioxidants. New York: Academic Press, 1991.